The success of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro caused the company to hike its guidance.The success of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro caused the company to hike its guidance.
BTC
$57,663.98
+1.69%
ETH
$2,323.18
-0.12%
LTC
$62.14
+1.18%
DASH
$24.02
+1.2%
XMR
$170.16
+0.17%
NXT
$0.00
+1.69%
ETC
$18.39
+0.73%
DOGE
$0.10
+1.11%
ZEC
$29.35
-1.23%
BTS
$0.00
+1.32%
DGB
$0.01
+0.21%
XRP
$0.56
+4.58%
BTCD
$547.95
+1.69%
PPC
$0.36
+5.02%
YBC
$2,883.20
+1.69%
Comments are closed.